Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway
The use of cisplatin as a chemotherapeutic drug is impeded by the development of drug resistance. Combination therapies of a chemosensitizer for cisplatin have been studied, but with little success, and the search for an effective combination therapy is continuing. Our earlier reports have shown tha...
Main Authors: | Thangjam Davis Singh, Ningthoujam Indrajit Singh, Khuraijam Mrinalini Devi, Remmei Meiguilungpou, Lhaineichong Khongsai, Lisam Shanjukumar Singh, Naresh Chandra Bal, Ningombam Swapana, Chingakham Brajakishor Singh, Thiyam Ramsing Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/21/7288 |
Similar Items
-
Anticancer properties and enhancement of therapeutic potential of cisplatin by leaf extract of Zanthoxylum armatum DC
by: Thangjam Davis Singh, et al.
Published: (2015-01-01) -
FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
by: D.V. Pilonetto, et al.
Published: (2009-03-01) -
Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway
by: Hai-Hong Lin, et al.
Published: (2024-01-01) -
Bioassay-Guided Isolation of 2-[p-(2-Carboxyhydrazino)phenoxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol from <i>Oroxylum indicum</i> and the Investigation of Its Molecular Mechanism Action of Apoptosis Induction
by: Asem Robinson Singh, et al.
Published: (2022-04-01) -
PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
by: Anna Huguet Ninou, et al.
Published: (2021-07-01)